Can integrated 18F-FDG PET/MR replace sentinel lymph node resection in malignant melanoma?

被引:16
作者
Schaarschmidt, Benedikt Michael [1 ]
Grueneisen, Johannes [2 ]
Stebner, Vanessa [3 ]
Klode, Joachim [4 ,5 ,6 ]
Stoffels, Ingo [4 ,5 ,6 ]
Umutlu, Lale [2 ]
Schadendorf, Dirk [4 ,5 ,6 ]
Heusch, Philipp [1 ]
Antoch, Gerald [1 ]
Poeppel, Thorsten Dirk [3 ]
机构
[1] Univ Dusseldorf, Dept Diagnost & Intervent Radiol, Med Fac, Dusseldorf, Germany
[2] Univ Duisburg Essen, Dept Diagnost & Intervent Radiol & Neuroradiol, Med Fac, Essen, Germany
[3] Univ Duisburg Essen, Dept Nucl Med, Med Fac, Essen, Germany
[4] Univ Duisburg Essen, Univ Hosp Essen, Dept Dermatol Venerol & Allergol, Essen, Germany
[5] Univ Duisburg Essen, West German Canc Ctr, D-45122 Essen, Germany
[6] Cierman Canc Consortium DKTK, D-69120 Heidelberg, Germany
关键词
PET; MRI; CT; Malignant melanoma; MM; DWI; POSITRON-EMISSION-TOMOGRAPHY; DUAL-MODALITY PET/CT; INITIAL EVALUATION; PROGNOSTIC-FACTORS; BIOPSY; CANCER; METASTASES; ULTRASOUND; ACCURACY; EXCISION;
D O I
10.1007/s00259-018-4061-9
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
PurposeTo compare the sensitivity and specificity of 18F-fluordesoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT), 18F-FDG PET/magnetic resonance (18F-FDG PET/MR) and 18F-FDG PET/MR including diffusion weighted imaging (DWI) in the detection of sentinel lymph node metastases in patients suffering from malignant melanoma.Material & MethodsFifty-two patients with malignant melanoma (female: n=30, male: n=22, mean age 50.516.0 years, mean tumor thickness 2.281.97mm) who underwent 18F-FDG PET/CT and subsequent PET/MR & DWI for distant metastasis staging were included in this retrospective study. After hybrid imaging, lymphoscintigraphy including single photon emission computed tomography/CT (SPECT/CT) was performed to identify the sentinel lymph node prior to sentinel lymph node biopsy (SLNB). In a total of 87 sentinel lymph nodes in 64 lymph node basins visible on SPECT/CT, 17 lymph node metastases were detected by histopathology. In separate sessions PET/CT, PET/MR, and PET/MR & DWI were assessed for sentinel lymph node metastases by two independent readers. Discrepant results were resolved in a consensus reading. Sensitivities, specificities, positive predictive values and negative predictive values were calculated with histopathology following SPECT/CT guided SLNB as a reference standard.Results p id=Par3 Compared with histopathology, lymph nodes were true positive in three cases, true negative in 65 cases, false positive in three cases and false negative in 14 cases in PET/CT. PET/MR was true positive in four cases, true negative in 63 cases, false positive in two cases and false negative in 13 cases. Hence, we observed a sensitivity, specificity, positive predictive value and negative predictive value of 17.7, 95.6, 50.0 and 82.3% for PET/CT and 23.5, 96.9, 66.7 and 82.3% for PET/MR. In DWI, 56 sentinel lymph node basins could be analyzed. Here, the additional analysis of DWI led to two additional false positive findings, while the number of true positive findings could not be increased.Conclusion p id="Par4 In conclusion, integrated 18F-FDG PET/MR does not reliably differentiate N-positive from N-negative melanoma patients. Additional DWI does not increase the sensitivity of 18F-FDG PET/MR. Hence, sentinel lymph node biopsy cannot be replaced by 18F-FDG-PE/MR or 18F-FDG-PET/CT.
引用
收藏
页码:2093 / 2102
页数:10
相关论文
共 40 条
[1]   Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology [J].
Antoch, G ;
Vogt, FM ;
Freudenberg, LS ;
Nazaradeh, F ;
Goehde, SC ;
Barkhausen, J ;
Dahmen, G ;
Bockisch, A ;
Debatin, JF ;
Ruehm, SG .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (24) :3199-3206
[2]   Non-small cell lung cancer: Dual-modality PET/CT in preoperative staging [J].
Antoch, G ;
Stattaus, J ;
Nemat, AT ;
Marnitz, S ;
Beyer, T ;
Kuehl, H ;
Bockisch, A ;
Debatin, JF ;
Freudenberg, LS .
RADIOLOGY, 2003, 229 (02) :526-533
[3]   Prognostic factors analysis of 17,600 melanoma patients: Validation of the American Joint Committee on Cancer melanoma staging system [J].
Balch, CM ;
Soong, SJ ;
Gershenwald, JE ;
Thompson, JF ;
Reintgen, DS ;
Cascinelli, N ;
Urist, M ;
McMasters, KM ;
Ross, MI ;
Kirkwood, JM ;
Atkins, MB ;
Thompson, JA ;
Coit, DG ;
Byrd, D ;
Desmond, R ;
Zhang, YT ;
Liu, PY ;
Lyman, GH ;
Morabito, A .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (16) :3622-3634
[4]   Adverse reactions to patent blue V dye - The NEW START and ALMANAC experience [J].
Barthelmes, L. ;
Goyal, A. ;
Newcombe, R. G. ;
McNeill, F. ;
Mansel, R. E. .
EJSO, 2010, 36 (04) :399-403
[5]   Futility of fluorodeoxyglucose F 18 positron emission tomography in initial evaluation of patients with T2 to T4 melanoma [J].
Clark, PB ;
Soo, V ;
Kraas, J ;
Shen, P ;
Levine, EA .
ARCHIVES OF SURGERY, 2006, 141 (03) :284-288
[6]   Melanoma, Version 2.2016 [J].
Coit, Daniel G. ;
Thompson, John A. ;
Algazi, Alain ;
Andtbacka, Robert ;
Bichakjian, Christopher K. ;
Carson, William E., III ;
Daniels, Gregory A. ;
DiMaio, Dominick ;
Ernstoff, Marc ;
Fields, Ryan C. ;
Fleming, Martin D. ;
Gonzalez, Rene ;
Guild, Valerie ;
Halpern, Allan C. ;
Hodi, F. Stephen, Jr. ;
Joseph, Richard W. ;
Lange, Julie R. ;
Martini, Mary C. ;
Materin, Miguel A. ;
Olszanski, Anthony J. ;
Ross, Merrick I. ;
Salama, April K. ;
Skitzki, Joseph ;
Sosman, Jeff ;
Swetter, Susan M. ;
Tanabe, Kenneth K. ;
Torres-Roca, Javier F. ;
Trisal, Vijay ;
Urist, Marshall M. ;
McMillian, Nicole ;
Engh, Anita .
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2016, 14 (04) :450-+
[7]  
El-Maraghi Robert H, 2008, J Am Coll Radiol, V5, P924, DOI 10.1016/j.jacr.2008.02.022
[8]   Positron emission tomography is not useful in detecting metastasis in the sentinel lymph node in patients with primary malignant melanoma stage I and II [J].
Fink, AM ;
Holle-Robatsch, S ;
Herzog, N ;
Mirzaei, S ;
Rappersberger, K ;
Lilgenau, N ;
Jurecka, W ;
Steiner, A .
MELANOMA RESEARCH, 2004, 14 (02) :141-145
[9]   Evidence-based and interdisciplinary consensus-based German guidelines: systemic medical treatment of melanoma in the adjuvant and palliative setting [J].
Garbe, Claus ;
Hauschild, Axel ;
Volkenandt, Matthias ;
Schadendorf, Dirk ;
Stolz, Wilhelm ;
Reinhold, Uwe ;
Kortmann, Rolf-Dieter ;
Kettelhack, Christoph ;
Frerich, Bernhard ;
Keilholz, Ulrich ;
Dummer, Reinhard ;
Sebastian, Guenther ;
Tilgen, Wolfgang ;
Schuler, Gerold ;
Mackensen, Andreas ;
Kaufmann, Roland .
MELANOMA RESEARCH, 2008, 18 (02) :152-160
[10]   Diagnosis and treatment of melanoma: European consensus-based interdisciplinary guideline [J].
Garbe, Claus ;
Peris, Ketty ;
Hauschild, Axel ;
Saiag, Philippe ;
Middleton, Mark ;
Spatz, Alain ;
Grob, Jean-Jacques ;
Malvehy, Josep ;
Newton-Bishop, Julia ;
Stratigos, Alexander ;
Pehamberger, Hubert ;
Eggermont, Alexander .
EUROPEAN JOURNAL OF CANCER, 2010, 46 (02) :270-283